{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-26-001940","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2026-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.950339+00:00","generated_at":"2026-05-15T08:04:42.583012+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"VolitionRx shareholders approve share issuance to Lind Global and reverse stock split authorization","bullets":["Proposal 1 (issuance >20% to Lind Global): 44.15M for, 14.10M against, 1.11M abstain, 21.15M broker non-votes approved.","Proposal 2 (reverse split authorization): 62.84M for, 16.45M against, 1.22M abstain; board may choose ratio 1:5 to 1:20.","Record date Feb 9, 2026: 135.57M shares outstanding; 80.51M shares present at special meeting on March 31, 2026.","No other matters were presented for stockholder action at the special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-001940","json":"https://secwatch.observer/filing/0001477932-26-001940.json","markdown":"https://secwatch.observer/filing/0001477932-26-001940.md","text":"https://secwatch.observer/filing/0001477932-26-001940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/0001477932-26-001940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793226001940/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:04:42.583012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}